The loss of TP53-mediated control over cell growth and survival allows for the accumulation of genetic mutations and resistance to apoptosis, further promoting the malignancy and aggressiveness of adult AML (Shetzer et al. 2016). The gene discussed is TP53; the disease is acute myeloid leukemia.